Cell culture and SLC12A1 intervene

FT Fei Teng
MG Meng Guo
FL Fang Liu
CW Ce Wang
JD Jiayong Dong
LZ Lei Zhang
YZ You Zou
RC Rui Chen
KS Keyan Sun
HF Hong Fu
ZF Zhiren Fu
WG Wenyuan Guo
GD Guoshan Ding
request Request a Protocol
ask Ask a question
Favorite

HEK293T cells were maintained in RPMI-1640 with 10% FBS. HCC cells were maintained in Dulbecco's modified Eaglemedium (DMEM) with 10% FBS, 1 mM glutamine. As for siRNA transfection, cells were seeded into plates and incubated overnight, and then transfected with RNAs using Oligofectamine™ (Invitrogen CA, USA). The cells were culturedand collected at 0, 24 and 48 h after transfection. Non-targeting siRNA with the following sequence was applied as a control: sense: UUCUCCGAACGUGUCACGUTT, anti-sense: ACGUGACACGUUCGGAGAATT. Three siRNA of SLC12A1 with the following sequences were designed: si-1: sense-CGCGCAAACUGUGUGUUAATT, antisense-UUAACACACAGUUUGCGCGTT; si-2: sense -GCUGGCAAGUUGAACAUUATT, antisense-UAAUG UUCAACUUGCAGCTT; si-3: sense-GUCCAGAGGUUU CUUUAAUTT, antisense-AUUAAAGAAACCUCUGGA CTT.

Lentivirus packed with dCas9-VP64 and MS2-P65-HSF1(SAM) was purchased from Hanbio Biotechnology (Shanghai, China). Lentivirus packed with dCas9-KRAB was purchased from YSY Biotechnology (Nanjing, China). The sgRNA was designed online at GENSCRIPT (http://www.genscript.com/gRNA-database), and had the following the sequence: sgSLC12A1-1: CAACTT AAGTACCACATCAAC; sgSLC12A1-2: CCTCAGGGC TAATGACCTGG; sgSLC12A1-3: GGGGCTTACAG TACTATTCC. The sgRNA was synthesized at Genebioseq (Shanghai, China) and assembled into restriction BsmBI sites of lentiGuide-Puro(Addgene plasmid 52963, a gift from Feng Zhang) following Zhang et al.'s protocol [47]. Recombinant plasmids (10μg) were cotransfected into HEK293T with lentiviral packaging vectors pRSV-REV (5 μg), pMDLg/pRRE (10 μg) and vesicular stomatitis virus G glycoprotein (VSVG) expression vector pMD2G (7.5 μg). After three days, the post-transfection culture supernatant was concentrated by ultracentrifugation for 1 h at 30,000 rpm, then resuspended in Hank's buffer. The titer was 5~107IU/mL.

The candidate cells were infected at 10 MOI of dCas9-VP64 or dCas9-KRAB and 5 MOI of each sgRNA in the presence of polybrene (6μg/mL), then cultured for further experiments.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A